Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Ossen Innovation Proposes Acquisition of China Glucose Monitoring Device Company

publication date: Aug 5, 2016
Ossen Innovation, a Shanghai company, plans to transform itself into a glucose monitoring medical device maker. Ossen has struck a deal to acquire the American-Asia Diabetes Research Foundation, whose San MediTech (Huzhou) subsidiary offers a continuous glucose monitoring device in China. Ossen will spin off its present business -- the manufacture of pre-stressed steel materials for bridges -- to a buyer group led by its current Chairman, Dr. Liang Tang. No financial details of the two transactions were disclosed. Board approval for the two deals is required. More details....

Stock Symbol: (NSDQ: OSN)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital